Esperion Therapeutics
ESPR
#6169
Rank
$0.88 B
Marketcap
$3.73
Share price
-1.58%
Change (1 day)
11.68%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): -$0.54

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.54. In 2024 the company made an earnings per share (EPS) of -$0.23 an increase over its 2023 EPS that were of -$2.12.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$0.54134.78%
2024-$0.23-89.15%
2023-$2.12-40.28%
2022-$3.55-62.87%
2021-$9.5680.38%
2020-$5.3050.14%
2019-$3.53-53.18%
2018-$7.547.41%
2017-$7.02110.81%
2016-$3.3347.35%
2015-$2.260.89%
2014-$2.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
-$5.94 1,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$2.72-603.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$1.72-418.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$43.44-8,144.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-$0.11-79.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-$0.19-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA